Formestane

福美坦

Report date: 2025/11/28 11:08:33
NME

Base Information

Drug NameFormestane
Drug Alias Name福美斯坦4-HydroxyandrostenedioneFormestane IM depot injection福美司坦formestanum +[18] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAromatase inhibitors
TargetsAromatase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsNeoplasms
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryCanada
Original Approved Date1994/12/31
Country/TerritoryCanadaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Schweiz Ag
Inactive CompaniesNovartis Pharmaceuticals Canada Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL02BG02
Related LinksWikipediaDrugBankKEGG